Related Experiment Videos
Revascularization interventions for ischemic heart disease
1Department of Internal Medicine, University of Texas Medical School at Houston and Memorial Hermann Hospital, 77030, USA.
Insights
Coronary artery bypass grafting and percutaneous transluminal coronary angioplasty are established myocardial revascularization methods. Patient-specific factors guide the choice between bypass grafting and angioplasty for optimal outcomes.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Medical Technology
Background:
- Coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) are primary myocardial revascularization techniques.
- The selection of revascularization strategy hinges on clinical and angiographic patient parameters.
Purpose of the Study:
- To compare the efficacy and patient selection criteria for CABG versus PTCA.
- To review advancements in revascularization techniques, including stenting and minimally invasive surgery.
Main Methods:
- Review of clinical guidelines and outcomes data for CABG and PTCA.
- Analysis of patient subgroups benefiting from specific revascularization approaches.
- Evaluation of emerging percutaneous and surgical techniques.
Main Results:
- CABG is preferred for left main or three-vessel disease with impaired left ventricular function.
- PTCA offers symptomatic relief for single-vessel disease without improving mortality.
- Outcomes for non-diabetic patients with multiple-vessel disease are similar for both methods; diabetic patients may benefit more from CABG.
- Stenting significantly improves PTCA outcomes; other novel percutaneous techniques lack proven superiority.
Conclusions:
- Treatment choice for coronary artery disease requires careful consideration of individual patient characteristics and disease extent.
- Stenting has become integral to percutaneous revascularization, enhancing both short- and long-term results.
- Transmyocardial laser revascularization may benefit refractory angina patients.
Abstract:
Coronary artery bypass grafting and percutaneous transluminal coronary angioplasty are now well established methods of myocardial revascularization. The choice of a method of revascularization depends on several clinical and angiographic parameters. Patients who derive the greatest benefit from coronary artery bypass grafting are those with left main coronary artery disease or those with three-vessel disease with left ventricular impairment. Patients with single-vessel disease achieve more symptomatic relief with coronary angioplasty than with medical therapy alone, but with no improvement in long-term mortality. In nondiabetic patients with multiple-vessel disease, angioplasty and bypass grafting likely yield similar results, and the choice of revascularization technique rests on weighing the more invasive nature of bypass grafting against the need for additional future revascularizations with angioplasty. Diabetic patients with multiple-vessel disease seem to achieve better outcomes with bypass grafting. Minimally invasive bypass surgery is an evolving technique. It is less invasive in nature but its applications are limited, and its advantages over traditional bypass grafting have not yet been shown. Stenting now plays a major role in percutaneous revascularization and is performed in more than two thirds of all interventional procedures. It improves both the short-term and the long-term outcomes of coronary angioplasty. Other novel percutaneous techniques such as directional or rotational atherectomy, laser angioplasty, or thrombectomy devices have not shown convincing superiority over coronary angioplasty alone. Transmyocardial laser revascularization can be performed surgically or percutaneously and may be beneficial in patients with angina refractory to traditional revascularization procedures.